⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

December 1, 1998British Journal of Haematology

A randomized double‐blind placebo‐controlled study with subcutaneous recombinant human erythropoietin in patients with low‐risk myelodysplastic syndromes

View Full Paper

Ask AI

Bookmark

Share

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

A 1998 study studied this question.

synapsesocial.com/papers/6a91728ccdcb4f7bdda1598d https://doi.org/10.1046/j.1365-2141.1998.01085.x

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia1991 · 64 citations
2Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model1997 · 314 citations
3International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes1997 · 4,487 citations
4Efficacy of erythropoietin in the myelodysplastic syndromes: a meta‐analysis of 205 patients from 17 studies1995 · 357 citations
5Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia1990 · 90 citations